Fluconazole

cytochrome P450 family 4 subfamily F member 3 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34143391 A Physiologically Based Pharmacokinetic and Drug-Drug Interaction Model for the CB2 Agonist Lenabasum. 2021 Jul 1
2 27063220 An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s. 2016 May 1
3 25148377 Cytochrome P450 epoxygenase dependence of opioid analgesia: fluconazole does not interfere with remifentanil-mediated analgesia in human subjects. 2014 Dec 2
4 15611610 Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis. 2004 2
5 12680714 Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient. 2003 6
6 14580893 Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole. 2003 Dec 10 4
7 9303380 Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients. 1997 Sep 1
8 8801056 Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies. 1996 Apr 2
9 8801058 Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction. 1996 Apr 2
10 7957514 Effect of fluconazole on theophylline disposition in humans. 1994 1
11 8173131 Fluconazole-induced symptomatic phenytoin toxicity. 1994 Feb 1
12 8247921 Possible interaction between warfarin and fluconazole. 1993 Sep-Oct 1
13 1394641 Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug-metabolism in mice and humans in vivo. Comparative study with ketoconazole. 1992 May 4